Optimizing Patient Selection to Maximize Drug Efficacy: the Expanding Role of Pharmacogenomics in the Clinical Development of Pembrolizumab for the Treatment of Non–Small Cell Lung Cancer

Cinzia Dello Russo*, Dimitri Gagliardi, Ronnie Ramlogan, Pierluigi Navarra

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Optimizing Patient Selection to Maximize Drug Efficacy: the Expanding Role of Pharmacogenomics in the Clinical Development of Pembrolizumab for the Treatment of Non–Small Cell Lung Cancer'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science